Are There Differences Between Carriers of Haemophilia A and B?
NCT05217992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 900
Last updated 2023-08-07
Summary
This study aims to develop a systematic genetic screening strategy for (potential) female carriers of haemophilia by identifying as many female carriers as possible within the families of haemophilia patients regularly followed at Cliniques universitaires Saint-Luc (CUSL) and to search for differences between female carriers of haemophilia A (HA) and B (HB).
Conditions
Interventions
- OTHER
-
Genetic assessment (hemophilia testing)
Determination of carrier ship of hemophilia with molecular tests
Sponsors & Collaborators
-
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
lead OTHER
Principal Investigators
-
Cedric Hermans, MD,PhD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Eligibility
- Min Age
- 12 Years
- Max Age
- 85 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-25
- Primary Completion
- 2023-04-30
- Completion
- 2023-04-30
Countries
- Belgium
Study Locations
More Related Trials
-
The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B
NCT03623295 ·Status: COMPLETED
-
Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
NCT05962398 ·Status: ENROLLING_BY_INVITATION
-
A Feasibility Study to Collect Data in Patients With Haemophilia
NCT00798499 ·Status: COMPLETED
-
A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care
NCT02049099 ·Status: COMPLETED
-
Socialization of Adult Men With Congenital Hemophilia A or B
NCT01510418 ·Status: COMPLETED
-
Hemophilia Inhibitor Genetics Study (HIGS)
NCT00166387 ·Status: COMPLETED
-
Chronic Pain and Hemophilia
NCT05202951 ·Status: RECRUITING
-
Learning to Live With Non-severe Haemophilia
NCT05314751 ·Status: COMPLETED
-
Genetic Susceptibility to Factor VIII Inhibitors
NCT00344435 ·Status: COMPLETED
-
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
NCT05568719 ·Status: RECRUITING ·Phase: PHASE3
-
A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture
NCT02402829 ·Status: TERMINATED
-
Epidemiology and Immunology of Hemophilia A Inhibitors
NCT00005518 ·Status: COMPLETED
-
Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia
NCT01439971 ·Status: COMPLETED ·Phase: PHASE1
-
Biomarkers Serum Collection Methodology Pilot Study
NCT01318707 ·Status: COMPLETED
-
Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B
NCT03287999 ·Status: UNKNOWN
-
Gait Evaluation in Haemophiliac Patients
NCT00824798 ·Status: COMPLETED
-
Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors
NCT00221195 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study Evaluating Inhibitor Specificity in Hemophilia A
NCT00151385 ·Status: WITHDRAWN ·Phase: PHASE4
-
Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast
NCT05279924 ·Status: COMPLETED ·Phase: NA
-
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
NCT02506023 ·Status: COMPLETED ·Phase: PHASE1
-
Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.
NCT03054662 ·Status: COMPLETED ·Phase: NA
-
Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A
NCT02256917 ·Status: COMPLETED ·Phase: PHASE3
-
Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients
NCT02540187 ·Status: COMPLETED
-
Monitoring of Anti-TFPI in Hemophilia
NCT07101926 ·Status: RECRUITING
-
The Second Multicenter Hemophilia Cohort Study
NCT00341705 ·Status: COMPLETED